The shifting demographic landscape of pandemic influenza

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Bansal, Shweta ^a,b   Pourbohloul, Babak ^c,d   Hupert, Nathaniel ^e,f   Grenfell, Bryan ^b,g   Meyers, Lauren Ancel ^h,i  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g PRINCETON UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS AT AUSTIN   (United States)

ⁱ SANTA FE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; MATHEMATICAL MODEL; PANDEMIC; URBAN POPULATION; VACCINATION; VIRUS STRAIN; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; EPIDEMIC; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA VIRUS A H1N1; MIDDLE AGED; POPULATION DYNAMICS; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; RISK ASSESSMENT; SEASON; STATISTICS; UNITED STATES; VIROLOGY;

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; POPULATION DYNAMICS; RISK ASSESSMENT; SEASONS; UNITED STATES; URBAN POPULATION; YOUNG ADULT;

EID: 77949756893     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009360     Document Type: Article

References (75)

1. Chan M (2009) Influenza A(H1N1): lessons learned and preparedness.
2. Centers for Disease Control and Prevention (2009) CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States : Accessed Feb 5, 2010.
3. Greenberg M, Lai M, Hartel G, Wichems C, Gittleson C (2009) Response to a Monovalent 2009 Influenza A (H1N1) Vaccine. NEJM 361(25).
4. Garcia-Garcia L, Valdespino-Gomez J, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A (2009) Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 339: 3928.
5. Centers for Disease Control and Prevention (2009) Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine. Morb Mortal Wkly Rep 58: 521-524.
6. Smith D, Lapedes A, de Jong J, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-6.
7. Bansal S, Pourbohloul B, Meyers L (2006) Comparative analysis of influenza vaccination programs. PLoS Medicine 3.
8. Meyers L, Newman M, Martin M, Schrag S (2003) Applying network theory to epidemics: control measures for mycoplasma pneumoniae outbreaks. Emerg Infect Dis 9.
9. Meyers L, Pourbohloul B, Newman M, Skowronski D, Brunham R (2005) Network theory and SARS: predicting outbreak diversity. J Theo Biol 232: 71-81.
10. Keeling M, Eames K (2005) Networks and epidemic models. J R Soc Interface 2: 295-307.
11. Keeling M (1999) The effects of local spatial structure on epidemiological invasions. Proc R Soc B 266: 859-867.
12. Bansal S, Grenfell B, Meyers L (2007) When Individual Behavior Matters: Homogeneous and Network Models in Epidemiology. J R Soc Interface 4(16): 879-91.
13. Jordan E (1927) Epidemic Influenza: A survey. Chicago: American Medical Association.
14. Barry J, Viboud C, Simonsen L (2008) Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J Infect Dis 198: 1427-34.
15. Foy H, Cooney M, Allan I (1976) Longitudinal studies of type a and b influenza among seattle schoolchildren and familiies. J Infect Dis 134: 362.
16. Noble G, Wulff H, Tegtmeier G, Clark P, Bender T, et al. (1974) Hong kong influenza. Am J Epidemiol 100: 517.
17. Pease C (1987) An evolutionary epidemiological mechanism, with applications to type a infuenza. Theoretical Population Biology 31: 422-452.
18. Finkenstadt B, Morton A, Rand D (2005) Modelling antigenic drift in weekly flu incidence. Am Stat 24: 3447-61.
19. Couch R, Kasel J (1983) Immunity to influenza in man. Annu Rev Microbiol 37: 529-549.
20. Glezen W, Couch R (1997) Viral Infections of Humans, Springer, chapter Influenza Viruses. pp 473-505.
21. Shulman J (1970) Effects of immunity on transmission of influenza: Experimental studies. Progr Med Virol 12: 128-16.
22. Murphy B, Kasel J, Chanock R (1972) Association of serum anti-neuraminidase antibody with resistance to influenza in man. NEJM 286: 1329-1332.
23. Couch R, Kasel J, Gerin J, Schulman J, Kilbourne E (1974) Induction of partial immunity to influenza by a neuraminidase-specific vaccine. Journal of Infectious Diseases 129: 411-20.
24. Bansal S, Meyers L (2009) The impact of past epidemics on future disease dynamics. arxiv 0910.2008.
25. Newman M (2002) Spread of epidemic disease on networks. Phys Rev E 66.
26. Medlock J, Galvani A (2009) Optimizing influenza vaccine distribution. Science : 1175570.
27. Centers for Disease Control and Prevention (2009) 2009 H1N1 Flu In The News. Accesssed Dec 22, 2009.
28. Nichol K (2003) The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21: 1769-1775.
29. Fiore A, Neuzil K (2010) 2009 Influenza A(H1N1) Monovalent Vaccines for Children. JAMA 303(1): 73-74.
30. Luk J, Gross P, Thompson W (2001) Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis 33: 1375-1378.
31. Dauer C, Serfling R (1961) Mortality from influenza, 1957-1958 and 1959-1960. Am Rev Respir Dis 83: 15-26.
32. Glezen W (1996) Emerging infections: pandemic influenza. Epidemiol Rev 181: 64-76.
33. Longini I, Koopman J, Monto A, Fox J (1982) Estimating household and community transmission parameters of influenza. Am J Epidemiol 115: 736-751.
34. Longini I, Halloran M (2005) Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 161: 303-306.
35. Taber L, Paredes A, Glezen W, Couch R (1982) Infection with influenza a/victoria virus in houston families. J Hyg Lond 86: 303-313.
36. Monto A, Kioumehr F (1975) The tecumseh study of respiratory illness. ix. occurrence of influenza in the community, 1966-1971. Am J Epidemiol 102: 553-63.
37. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Kerkhove MDV, et al. (2009) Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings. Science 324: 1557-1561.
38. Nishiura H, Castillo-Chavez C, Safan M, Chowell G (2009) Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Eurosurveillance 14: 22.
39. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature; doi:10.1038/nature08260.
40. Mossong J, Hens N, Jit M, Beutels P, Auranen K (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 5: 3.
41. Read J, Eames K, Edmunds W (2008) Dynamic social networks and the implications for the spread of infectious disease. J R Soc Interface 5(26): 1001-1007.
42. Beutels P, Shkedy Z, Aerts M, Van Damme P (2006) Social mixing pattern of transmission models of close contact infections. Epidemiol Infect 134: 1158-1166.
43. Wallinga J, Teunis P, Kretzschmar M (2006) Using data on social contacts of estimate age-specific transmission parameters for respiratory-spread pathogens. Am J Epidemiol 164: 936-44.
44. Eubank S (2008) Synthetic data products for societal infrastructures and proto-populations: Data set 2.0. Technical Report NDSSL-TR-07-003, Network Dynamics and Simulation Science Laboratory, Virginia Polytechnic Institute and State University.
45. Anderson R, May R (1991) Infectious diseases of humans. London: Oxford University Press.
46. Barbour A, Mollison D (1990) Stochastic Processes in Epidemic Theory, Springer, chapter Epidemics and random graphs. pp 86-89.
47. Barthelemy M, Barrat A, Pastor-Satorras R, Vespignani A (2004) Velocity and hierarchical spread of epidemic outbreaks in scale-free networks. Phys Rev Lett 92.
48. Ferrari M, Bansal S, Meyers L, Bjornstad O (2006) Network frailty and the geometry of herd immunity. Proc of R Soc 273: 2743-2748.
49. Pourbohloul B, Ahued A, Davoudi B, Meza R, Meyers L, et al. (2009) Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza and Other Respiratory Viruses 3(5): 215-22.
50. Taubenberger J, Morens D (1996) 1918 influenza: the mother of all pandemics. Emerg Infect Dis 12(1): 15-22.
51. Nguyen-Van-Tam J, Hampson A (2003) The epidemiology and clinical impact of pandemic influenza. Vaccine 21: 1762-1768.
52. Longini IJ, Halloran M, Nizam A, Yang Y (2004) Containing pandemic influenza with antiviral agents. Am J Epidemiol 159: 623-633.
53. Reichart T, Sugaya N, Fedson D, Glezen W, Simonsen L (2001) The japanese experience with vaccinating school-children against influenza. N Engl J Med 344: 889-896.
54. Monto A, Koopman J, Longini IJ (1985) The tecumseh study of illness. xiii. influenza infection and disease. Am J Epidemiol 121: 811-822.
55. Advisory Committee on Immunization Practices, CDC (2009) Novel H1N1 Vaccination Recommendations : Accessed August 5.
56. Pastor-Satorras R, Vespignani A (2001) Immunization of complex networks. Phys Rev E 65: 036104.
57. Dezso Z, Barabasi AL (2001) Halting viruses in scale-free networks. Phys Rev E 65: 055103.
58. Woolhouse M, Dye C, Etard J, Smith T, Charlwood J (1997) Heterogeneities in the transmission of infectious agents: implications for the design of control programs. PNAS 94: 338-342.
59. Meltzer M, Cox N, Fukuda K (1999) The economic impact of pandemic influenza in the united states: Priorities for intervention. Emerg Infect Dis 5: 659-71.
60. Wallinga J, Edmunds W, Kretzschmar M (1999) Perspective: human contact patterns and the spread of airborne infectious diseases. Trends Microbiol 7: 372-377.
61. Collins S (1957) Influenza in the united states, 1887-1956. Public Health Monograph 48.
62. Frost W (1920) Statistics of influenza morbidity: with special reference to certain factors in case incidence. Public Health Reports 36: 584-597.
63. Viboud C, Bjornstad O, Smith D, Simonsen L, Miller M, et al. (2006) Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 312: 447-51.
64. Centers for Disease Control and Prevention (2009) Flu view: 2009-2010 influenza season week 48 ending december 5, 2009.
65. Simonsen L, Clarke M, Schonberger L, Adren N, Cox N, et al. (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178: 53-60.
66. Collins S (1931) Age and sex incidence of influenza and pneumoniae morbidity and mortality in the epidemic of 19289-1929 with comparative data for teh epidemic of 1918-1919. Public Health Reports 46: 1909-36.
67. Gilbert V, Caraway C, Bruce J, Mogabgab W (1962) Epidemic recurrence of asian influenza in lousiana, 1959-1960. Am J Public Health 52: 1432-43.
68. Denniston G (1962) "influenza surveillance". Technical Report 70, Communicable Disease Center.
69. Perrott G, Linder F (1958) Data on acute upper respiratory diseases. Public Health Rep 73(2): 121-8.
70. Davis L, Caldwell G, Lynch R, Bailey R, Chin T (1970) Hong kong influenza: the epidemiologic features of a high school family study analyzed and compared with a similar study during the 1957 asian influenza epidemic. Am J Epidemiol 92: 240-7.
71. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, et al. (2005) Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis 11(9).
72. Taylor M (1971) Influenza 1969-1970. J R Coll Gen Practit 21(17).
73. Secretaria de Salud (Accessed June 15, 2009) Estadisticas influenza.
74. Centers for Diease Control and Prevention (May 19, 2009) S-oiv case count by age strata. CDC Complete Line List.
75. Schulman J, Kilbourne E (1969) Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus. PNAS 63: 326-33.